KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

BACKGROUND: Gliomas are one of the most lethal cancers in the human central nervous system. Despite clinical treatment advancements, the prognosis of patients with glioma remains poor. KDM2B is a histone lysine demethylase, which has been observed in multiple tumors. But the concrete role of KDM2B i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiwei, Zang, Jin, Zhang, Dongyong, Sun, Zhenxiang, Qiu, Bo, Wang, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764301/
https://www.ncbi.nlm.nih.gov/pubmed/29386904
http://dx.doi.org/10.2147/OTT.S149833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764301/
https://www.ncbi.nlm.nih.gov/pubmed/29386904
http://dx.doi.org/10.2147/OTT.S149833

Ejemplares similares